{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:05:12Z","timestamp":1793462712025,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jdiacomp.2024.108718","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T03:16:12Z","timestamp":1709608572000},"page":"108718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of denosumab on inflammation and bone health in active Charcot foot: A phase II randomised controlled trial"],"prefix":"10.1016","volume":"38","author":[{"given":"Joel Willem Johan","family":"Lasschuit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline Ruth","family":"Center","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry Richard","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine Thuy Trang","family":"Tonks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2024.108718_bb0005","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0140-6736(05)67029-8","article-title":"The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes","volume":"366","author":"Jeffcoate","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0010","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2337\/dc21-2508","article-title":"The Charcot foot reflects a response to injury that is critically distorted by preexisting nerve damage: an imperfect storm","volume":"45","author":"Jeffcoate","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00592-021-01803-w","article-title":"Contribution of peripheral neuropathy to poor bone health in the feet of people with type 2 diabetes mellitus","volume":"59","author":"Lasschuit","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0020","first-page":"84","article-title":"Role of neuropathy on fracture healing in Charcot neuro-osteoarthropathy","volume":"10","author":"Mabilleau","year":"2010","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1464-5491.2001.00511.x","article-title":"Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover","volume":"18","author":"Jirkovska","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0030","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/dme.14183","article-title":"Comparison of calcaneal quantitative ultrasound and bone densitometry parameters as fracture risk predictors in type 2 diabetes mellitus","volume":"37","author":"Lasschuit","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0035","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2337\/dc10-0636","article-title":"A prospective study of calcaneal bone mineral density in acute Charcot osteoarthropathy","volume":"33","author":"Petrova","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0040","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2106\/JBJS.L.00250","article-title":"Progression of foot deformity in Charcot neuropathic osteoarthropathy","volume":"95","author":"Hastings","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0045","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jdiacomp.2017.02.005","article-title":"Persistent inflammation with pedal osteolysis 1year after Charcot neuropathic osteoarthropathy","volume":"31","author":"Sinacore","year":"2017","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0050","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diacare.28.5.1214","article-title":"Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial","volume":"28","author":"Pitocco","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259224","article-title":"Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus","volume":"16","author":"Das","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0060","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/dc11-0396","article-title":"The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial","volume":"34","author":"Pakarinen","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00125-011-2354-7","article-title":"Audit of acute Charcot\u2019s disease in the UK: the CDUK study","volume":"55","author":"Game","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0070","doi-asserted-by":"crossref","DOI":"10.2337\/dc17-1517","article-title":"Effect of single dose of RANKL antibody treatment on acute Charcot neuro-osteoarthropathy of the foot","volume":"41","author":"Busch-Westbroek","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0075","first-page":"S464","article-title":"Denosumab, compared to standard care alone, reduces disease activity of acute diabetes related Charcot neuropathy (poster session, 55th EASD annual meeting)","volume":"62","author":"Lau","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0080","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2337\/dc08-9021","article-title":"Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists","volume":"31","author":"Boulton","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0085","first-page":"2015","article-title":"Different approaches to bone densitometry","volume":"41","author":"Fogelman","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13047-020-00421-z","article-title":"Infrared dermal thermometry is highly reliable in the assessment of patients with Charcot neuroarthropathy","volume":"13","author":"Dallimore","year":"2020","journal-title":"J Foot Ankle Res"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0095","first-page":"317","article-title":"Monitoring healing of acute Charcot\u2019s arthropathy with infrared dermal thermometry","volume":"34","author":"Armstrong","year":"1997","journal-title":"J Rehabil Res Dev"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0100","series-title":"SF-36 Health Survey: Manual and Interpretation Guide","author":"Ware","year":"1993"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0105","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","article-title":"Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial","volume":"44","author":"Jude","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0110","article-title":"Diagnosis and treatment of active charcot neuro-osteoarthropathy in persons with diabetes mellitus: a systematic review","author":"Raspovic","year":"2023","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0115","year":"2016","journal-title":"EU Clinical Trials Register"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0120","article-title":"Efficacy of treatment with DENOsumab of an acute CHARCOT foot in patients with diabetes","year":"2020","journal-title":"Clin Trials"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.fas.2012.12.007","article-title":"Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: a prospective randomized trial","volume":"19","author":"Pakarinen","year":"2013","journal-title":"Foot Ankle Surg"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11136-005-3570-8","article-title":"Health status assessed by the SF-36 along the diabetes continuum in an Australian population","volume":"15","author":"Chittleborough","year":"2006","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0135","series-title":"Cat. no. 4399.0. Canberra: Australian Bureau of Statistics","author":"National Health Survey SF-36 Population Norms","year":"1995"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1071100713517097","article-title":"Self-reported quality of life in patients with diabetes: a comparison of patients with and without Charcot neuroarthropathy","volume":"35","author":"Raspovic","year":"2014","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0145","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3113\/FAI.2011.0867","article-title":"Precision of foot alignment measures in Charcot arthropathy","volume":"32","author":"Hastings","year":"2011","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0150","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2337\/dc21-0008","article-title":"Effect of recombinant human parathyroid hormone (1-84) on resolution of active Charcot neuro-osteoarthropathy in diabetes: a randomized, double-blind","volume":"44","author":"Petrova","year":"2021","journal-title":"Placebo-Controlled Study Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0155","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1177\/1071100714547218","article-title":"Radiographic analysis of diabetic midfoot charcot neuroarthropathy with and without midfoot ulceration","volume":"35","author":"Wukich","year":"2014","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0160","series-title":"Limb Salvage of the Diabetic Foot: An Interdisciplinary Approach","article-title":"Charcot foot: Investigations","author":"Petrova","year":"2019"},{"key":"10.1016\/j.jdiacomp.2024.108718_bb0165","series-title":"International Physical Activity Questionnaire","year":"2002"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:18:29Z","timestamp":1761005909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872724000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1056872724000448"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108718","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of denosumab on inflammation and bone health in active Charcot foot: A phase II randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108718"}}